Penumbra PEN
NYSE PEN
$325.18 +1.42 (+0.44%)
At close: Aug 21, 2026 · 4:00 PM EDT

Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026)

Penumbra (PEN) posted quarterly Change in Acquisitions & Divestments of $128.5 million for Q2 2026, up 2.66% quarter-over-quarter from $125.1 million in Q1 2026.

Penumbra (PEN) Change in Acquisitions & Divestments (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Change in Acquisitions & Divestments for 13 consecutive years, with $128.5 million the latest figure, recorded in Q2 2026.

  • In Q2 2026, Change in Acquisitions & Divestments changed N/A year-over-year to $128.5 million; the TTM figure through Jun 2026 stood at $253.6 million (up 317.88% YoY), while the FY2025 annual figure was $13.0 million, down 90.05% from the prior year.
  • Change in Acquisitions & Divestments improved to $128.5 million in Q2 2026 per PEN's latest filing, from $125.1 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $128.5 million in Q2 2026 and bottomed at $4.8 million in Q4 2024.
  • Historically, Change in Acquisitions & Divestments has averaged $36.8 million across 5 years, with a median of $20.7 million in 2022.
  • Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments plunged 86.85% — and 2026, when it jumped 862.61%.
  • Penumbra's Change in Acquisitions & Divestments stood at $12.2 million in 2022, then jumped by 199.26% to $36.5 million in 2023, then slumped by 86.85% to $4.8 million in 2024, then jumped by 170.83% to $13.0 million in 2025, then soared by 888.25% to $128.5 million in 2026.
  • Business Quant data shows PEN's Change in Acquisitions & Divestments at $128.5 million in Q2 2026, $125.1 million in Q1 2026, and $13.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Penumbra 12.80 Bn 12.14 Bn 264.94 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 128.47 Mn
Jun 30, 2026 128.47 Mn
Mar 31, 2026 125.14 Mn
Mar 31, 2026 125.14 Mn
Mar 31, 2025 13.00 Mn
Mar 31, 2025 13.00 Mn
Dec 31, 2024 4.80 Mn
Dec 31, 2024 4.80 Mn
Sep 30, 2024 42.89 Mn
Sep 30, 2024 42.89 Mn
Jun 30, 2024 39.55 Mn
Jun 30, 2024 39.55 Mn
Mar 31, 2024 43.38 Mn
Mar 31, 2024 43.38 Mn
Dec 31, 2023 36.50 Mn
Dec 31, 2023 36.50 Mn
Sep 30, 2023 18.10 Mn
Sep 30, 2023 18.10 Mn
Jun 30, 2023 13.37 Mn
Jun 30, 2023 13.37 Mn